We are monitoring the impact of COVID-19 on Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 212
Share on
Share on

Global Antifungal Drugs Market Size, Share, Trends, Growth & COVID-19 Impact Analysis Report – Segmented By Drug Type, Therapeutic Indications, Application & Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 212
Pages: 145

Global Antifungal Drugs Market Size (2020 to 2025)

As per our report, the global antifungal drugs market size was worth USD 13.06 billion in 2020. It is further estimated to be growing at a CAGR of 3.68% and value USD 15.65 billion by 2025. The market is expected to grow enormously in the next few years, with the growing global population.

Antifungal drugs are mainly used to treat various infections like athlete’s foot, ringworm, candidiasis, and others. These drugs can be easily obtained through a doctor’s prescription, whereas some are available over the counter. The drugs are manufactured with different formulas for various infections accordingly. Fungal infections occur due to the occurrence of organism feed by breaking down the living tissue, also known as dermatophytes. They can utilize keratin and cause infection over skin, hair, and nails. The only aim of these drugs is to prevent the fungal cell from growing by making the cell's contents break out. Unhygienic environments may lead to a severe condition in causing an infection on the skin.

MARKET DRIVERS:

Increasing awareness over the products' availability through digital advertisements and campaigns thrives the demand of the global antifungal drugs market majorly.

Changes in the environmental conditions and a rise in the spread of various infectious diseases from person to person, and the growing number of fungal infections such as aspergillosis and candidiasis further propel the growth of the global antifungal drugs market. The rise in the concern towards health and growing support from the government and non-government organizations over antifungal diseases is predicted to add fuel to the market's growth rate during the forecast period.

Adopting the latest technologies in producing various drugs and offering effective treatment procedures for different infectious diseases worldwide is to set up growth opportunities for the market. A rise in the demand to improve safety levels is lavishing the demand of this market. Furthermore, increasing investments in research and development institutes are ascribed to bolster the growth of the market.

MARKET RESTRAINTS:

The availability of alternate substitutes is silently hindering the growth of the global antifungal drugs market.

The rise in side effects with long-term use of these drugs has been a challenging market growth factor. Also, fluctuations in the drugs' production rate are slowly inhibiting the demand of the antifungal drugs market. Lack of skilled persons in manufacturing the drugs is also impeding the growth rate of the market. Stringent rules and regulations by the government in approving new drugs also limit the demand of the market.

Impact of COVID-19 on the global antifungal drugs market:

The introduction of COVID-19 has created an acceleration in the growth rate of the global antifungal drugs market. Patients with critical COVID-19 found to have small amounts of Interferon’s (IFNs) in the blood or lungs. As per the research published in the British Journal of Pharmacology, two medicines are available for preventing COVID-19, which are an antifungal drug and an antidepressant. Patients with COVID-19 are exposed to develop pulmonary aspergillosis and found that the antifungal itraconazole and antidepressant fluoxetine stopped producing the infectious disease COVID-19 virus amid the cell culture lab test. The drug is used in combination with the antiviral drug remdesiver, and the combination exhibited a collective effect and restricted the virus production. Influential and safeguarding drug combination treatment of Isotretinoin and antifungal drugs works as a potential aerosol therapy for COVID-19 patients. Thus, with the COVID-19 favor, the global antifungal drugs market is expected to register new growth heights during the forecast period.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Drug Type, Therapeutic Indications, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This market research report on the global antifungal drugs market has been segmented and sub-segmented based on drug type, therapeutic indications, application, and region.

Antifungal Drugs Market - By Drug Type:

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

Based on drug type, Echinocandins drug type is ruling with the highest shares of the market. The increasing scale of pharmaceutical industries is boosting up the demand of the market. Also, growing awareness camps through government organizations, especially in rural areas, are spurring the need for this market.

Antifungal Drugs Market - By Therapeutic Indications:

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

Antifungal Drugs Market - By Application:

  • Powders
  • Ointments
  • Drugs
  • Pastes

Based on the application, growing knowledge over the dosage levels among physicians or doctors in hospitals significantly influences the demand of the market. The rise in the need to increase productivity with growing incidences is likely to outshine the market's growth.

Antifungal Drugs Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American antifungal drugs market is predicted to occupy most of the market share in the global market during the forecast period due to the rapid adoption of the latest technologies. The introduction of various types of drugs with high quality and low cost is prompting the growth rate of the market in this region. During the forecast period, the European antifungal drugs market is expected to be the second-largest regional market in the global market. Increasing funds from private and public organizations to evaluate quality treatment procedures is surging the growth of the European antifungal drugs market. However, the Asia Pacific antifungal drugs market is forecasted to be the fastest-growing region globally between 2021 to 2026. It is estimated to register a tremendous growth rate in the foreseen years. An increasing number of infectious disease cases due to unhygienic environments in rural areas is a significant factor magnifying the growth of the market. The Middle East and Africa are anticipated to have substantial growth opportunities in the near future.

KEY MARKET PARTICIPANTS:

Noteworthy players leading the global antifungal drugs market are profiled in this report are Gilead Sciences, Inc., Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.

RECENT HAPPENINGS IN THIS MARKET:

  • In January 2020, the FDA approved its supplement New Drug Application (sNDA) for MYCAMINE to support the treatment of Candidemia.  
  • In December 2019, Astellas Pharma Inc. and Xyphos Biosciences, Inc. announced that Astellas had acquired Xiphos. With the acquisition, Astellas will gain Xyphos novel and proprietary ACCEL technology platform and industry-leading immune-oncology talent. 
  • In October 2019, Astellas committed nearly $13Million to fund Boston – Area Start-Up Innovation in Cell and Gene Therapy. 
  • In October 2019, Pandion Therapeutics and Astellas Pharma Inc. announced the signing of a License and Collaboration Agreement directed toward the research, development, and commercialization of locally acting immune modulators for autoimmune diseases for the pancreas. 
  • In December 2019, Astellas Pharma Inc., a Tokyo-based company, ALPMY, announced that it had acquired privately-held development-stage biotechnology company Xyphos Biosciences, Inc. to boost its immune-oncology pipeline. 
  • In November 2019, Astellas Pharma Inc. announced that the China National Medical Products Administration (NMPA) approved a new drug application for XTANDI to treat adult men with metastatic castration-resistant prostate cancer that is asymptomatic or mildly symptomatic. 
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Drug Type
      1. Echinocandins
      2. Azoles
      3. Polyenes
      4. Allylamines
      5. Others
    2. By Therapeutic Indications
      1. Aspergillosis
      2. Dermatophytosis
      3. Candidiasis
      4. Others
    3. By Application
      1. Powders
      2. Ointments
      3. Drugs
      4. Pasters
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia
    4. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Alternaria
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pfizer
    3. Novartis
    4. Sanofi-Aventis
    5. Merck & Co.
    6. Asperqillus
    7. Kramer Laboratories
    8. Bayer Healthcare
    9. Enzon Pharmaceuticals
    10. Glaxosmithkline Gilead
    11. Abbott Laboratories
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3.  Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  2. Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  3. Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  4. Azoles Market, By Region, From 2020 to 2025 (USD Million)
  5. Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  6. Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  7. Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  8. Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  9. Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  10. Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  11. Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  12. Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  13. Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  14. Powders Market, By Region, From 2020 to 2025 (USD Million)
  15. Ointments Market, By Region, From 2020 to 2025 (USD Million)
  16. Drugs Market, By Region, From 2020 to 2025 (USD Million)
  17. Pastes Market, By Region, From 2020 to 2025 (USD Million)
  18. North America Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  19. North America Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  20. North America Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  21. North America Azoles Market, By Region, From 2020 to 2025 (USD Million)
  22. North America Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  23. North America Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  24. North America Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  25. North America Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  26. North America Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  27. North America Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  28. North America Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  29. North America Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  30. North America Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  31. North America Powders Market, By Region, From 2020 to 2025 (USD Million)
  32. North America Ointments Market, By Region, From 2020 to 2025 (USD Million)
  33. North America Drugs Market, By Region, From 2020 to 2025 (USD Million)
  34. North America Pastes Market, By Region, From 2020 to 2025 (USD Million)
  35. United States Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  36. United States Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  37. United States Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  38. Canada Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  39. Canada Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  40. Canada Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  41. Europe Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  42. Europe Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  43. Europe Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  44. Europe Azoles Market, By Region, From 2020 to 2025 (USD Million)
  45. Europe Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  46. Europe Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  47. Europe Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  48. Europe Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  49. Europe Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  50. Europe Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  51. Europe Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  52. Europe Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  53. Europe Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  54. Europe Powders Market, By Region, From 2020 to 2025 (USD Million)
  55. Europe Ointments Market, By Region, From 2020 to 2025 (USD Million)
  56. Europe Drugs Market, By Region, From 2020 to 2025 (USD Million)
  57. Europe Pastes Market, By Region, From 2020 to 2025 (USD Million)
  58. U.K Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  59. U.K Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  60. U.K Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  61. Spain Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  62. Spain Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  63. Spain Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  64. Germany Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  65. Germany Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  66. Germany Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  67. Italy Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  68. Italy Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  69. Italy Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  70. France Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  71. France Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  72. France Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  73. Asia-Pacific Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  74. Asia-Pacific Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  75. Asia-Pacific Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  76. Asia-Pacific Azoles Market, By Region, From 2020 to 2025 (USD Million)
  77. Asia-Pacific Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  78. Asia-Pacific Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  79. Asia-Pacific Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  80. Asia-Pacific Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  81. Asia-Pacific Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  82. Asia-Pacific Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  83. Asia-Pacific Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  84. Asia-Pacific Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  85. Asia-Pacific Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  86. Asia-Pacific Powders Market, By Region, From 2020 to 2025 (USD Million)
  87. Asia-Pacific Ointments Market, By Region, From 2020 to 2025 (USD Million)
  88. Asia-Pacific Drugs Market, By Region, From 2020 to 2025 (USD Million)
  89. Asia-Pacific Pastes Market, By Region, From 2020 to 2025 (USD Million)
  90. China Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  91. China Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  92. China Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  93. India Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  94. India Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  95. India Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  96. Japan Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  97. Japan Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  98. Japan Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  99. South Korea Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  100. South Korea Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  101. South Korea Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  102. Australia Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  103. Australia Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  104. Australia Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  105. Latin America Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  106. Latin America Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  107. Latin America Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  108. Latin America Azoles Market, By Region, From 2020 to 2025 (USD Million)
  109. Latin America Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  110. Latin America Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  111. Latin America Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  112. Latin America Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  113. Latin America Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  114. Latin America Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  115. Latin America Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  116. Latin America Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  117. Latin America Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  118. Latin America Powders Market, By Region, From 2020 to 2025 (USD Million)
  119. Latin America Ointments Market, By Region, From 2020 to 2025 (USD Million)
  120. Latin America Drugs Market, By Region, From 2020 to 2025 (USD Million)
  121. Latin America Pastes Market, By Region, From 2020 to 2025 (USD Million)
  122. Brazil Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  123. Brazil Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  124. Brazil Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  125. Argentina Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  126. Argentina Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  127. Argentina Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  128. Mexico Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  129. Mexico Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  130. Mexico Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  131. Rest of Latin America Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  132. Rest of Latin America Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  133. Rest of Latin America Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  134. Middle East & Africa Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  135. Middle East & Africa Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  136. Middle East & Africa Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  137. Middle East & Africa Azoles Market, By Region, From 2020 to 2025 (USD Million)
  138. Middle East & Africa Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  139. Middle East & Africa Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  140. Middle East & Africa Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  141. Middle East & Africa Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  142. Middle East & Africa Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  143. Middle East & Africa Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  144. Middle East & Africa Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  145. Middle East & Africa Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  146. Middle East & Africa Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  147. Middle East & Africa Powders Market, By Region, From 2020 to 2025 (USD Million)
  148. Middle East & Africa Ointments Market, By Region, From 2020 to 2025 (USD Million)
  149. Middle East & Africa Drugs Market, By Region, From 2020 to 2025 (USD Million)
  150. Middle East & Africa Pastes Market, By Region, From 2020 to 2025 (USD Million)
  151. Middle East Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  152. Middle East Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  153. Middle East Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  154. Africa Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  155. Africa Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  156. Africa Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample